Symptoms And Complications Significantly Increase The Logistic And Economic Burden Of Obstructive Hypertrophic Cardiomyopathy - Results From Medical And Pharmacy Claims Data
Sanika Amonkar,Meiling Chen,Eros Papademetriou,Ravi Potluri,David Rotter,Michael Butzner,Theodore Abraham
DOI: https://doi.org/10.1016/j.cardfail.2023.10.173
IF: 6.592
2024-01-01
Journal of Cardiac Failure
Abstract:Background About 2/3 of patients with hypertrophic cardiomyopathy (HCM) have obstructive hemodynamics (oHCM) and there is limited evidence on the complication burden of this disease. Therefore, the Symphony Integrated Dataverse medical and pharmacy claims database was utilized to understand the impact of symptoms and complications in oHCM on health care logistics and economics. Hypothesis We hypothesize that presence of symptoms and complications significantly increase the logistic and economic burden of oHCM. Methods Adult patients with symptomatic (SYMP) and asymptomatic (ASYMP) oHCM were identified by ICD10 diagnosis codes between 2016-2021. Those with fatigue, chest pain, syncope, dyspnea, heart failure (HF), palpitations, pacemaker insertion, or septal reduction therapy, before or after 3 months of index date were defined as SYMP. Complications assessed between SYMP and ASYMP patients were atrial fibrillation(AF)/flutter, ventricular fibrillation/tachycardia (VF/VT), supraventricular tachycardia, stress cardiomyopathy and HF. Pre vs. post complication comparisons were expressed as mean per-person-per-year (PPPY) and are presented in Figure. Results We identified 16,123 unique oHCM patients (9,490 SYMP; 6,633 ASYMP). SYMP patients were older (61 vs 60 years, p<0.001), had a higher proportion of women (56% vs 46%, p<0.001) and higher incident rates of complications (0.880 vs. 0.518 per 1000 patient years, p<0.001; hazard ratio 0.58, 95% CI: 0.51 - 0.66). The 3 most frequent complications were HF, AF and VT. In SYMP patients, increased complications were associated with increased inpatient (IP) admissions (0.38 to 0.70 PPPY; p<0.001), outpatient (OP) visits (12.57 to 13.85 PPPY; p=0.035), and a non-significant increase in all-cause charges ($67,471 to $76,836 PPPY; p=0.289), respectively. Similarly, in ASYMP patients, increased complications were associated with increased IP admissions (0.07 to 0.23 PPPY; p=0.022), OP visits (6.01 to 10.38; p 0.001), and all-cause charges ($20,948 to $59,417 PPPY; p=0.001), respectively. Increment in pre vs. post complication charges was $9,365 vs. $38,469 PPPY in SYMP vs. ASYMP (p=0.049), respectively. Conclusions In a large cohort of patients with oHCM from a nationwide all-payer database, SYMP oHCM patients have higher rates of complications, IP admissions/ OP visits and healthcare charges. In SYMP and ASYMP, complications are associated with significant increases in IP/OP admissions and care charges. Our data may support an early intervention strategy to potentially avoid complications, especially in ASYMP patients, wherein there is a steep increment in charges.
cardiac & cardiovascular systems